You have 5 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

intensive chemotherapy

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leukemia, Myeloid, Acute Trial in Worldwide (Azacitidine, Cusatuzumab)

Active, not recruiting
  • Leukemia, Myeloid, Acute
  • Darlinghurst, Australia
  • +55 more
Dec 28, 2022

Acute Myeloid Leukemia Real World Treatment Patterns

Withdrawn
  • Leukemia, Myeloid, Acute
  • (no location specified)
Feb 16, 2021

Acute Myeloid Leukemia (AML), Acute Lymphocytic Leukemia in Relapse, Burkitt's Lymphoma Stage III Trial in Hartford, Calgary,

Recruiting
  • Acute Myeloid Leukemia (AML)
  • +4 more
  • Individualized Yoga Intervention Group
  • iPad Activity Control Group
  • Hartford, Connecticut
  • +2 more
Sep 16, 2021

Acute Leukemia Trial (KinHémo)

Not yet recruiting
  • Acute Leukemia
  • KinHémo
  • (no location specified)
Sep 15, 2021

Breast Cancer, Neutropenia Trial in Beijing (PEG-rhG-CSF)

Completed
  • Breast Cancer
  • Neutropenia
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Oct 26, 2020

Acute Myeloid Leukemia Trial in United States (Quizartinib, Milademetan)

Terminated
Has Results
  • Acute Myeloid Leukemia
  • Los Angeles, California
  • +7 more
Mar 14, 2022

Acute Myeloid Leukemia Trial in France (Dexamethasone)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Angers, France
  • +24 more
Jul 26, 2022

Acute Myeloid Leukemia Trial in Worldwide (Magrolimab, Venetoclax, Azacitidine)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Magrolimab
  • +6 more
  • Duarte, California
  • +25 more
Feb 4, 2022

AML, Adult Trial in Chicago, Charlottesville (BST-236, venetoclax)

Recruiting
  • AML, Adult
  • Chicago, Illinois
  • +1 more
Aug 17, 2022

Gene Mutations in Triple-negative and HER2+ Breast Cancer

Active, not recruiting
  • Breast Cancer
    • Athens, Greece
      George Fountzilas
    Mar 15, 2022

    Hypomethylating Agents and Venetoclax in Newly Diagnosed Acute

    Recruiting
    • Acute Myeloid Leukemia, Adult
    • +2 more
    • Trieste, Italy
      SC Ematologia Ospedale Maggiore
    Sep 14, 2020

    Acute Myeloid Leukemia (AML) Trial in Worldwide (standard combination chemo, decitabine)

    Active, not recruiting
    • Acute Myeloid Leukemia (AML)
    • Edegem, Antwerpen, Belgium
    • +52 more
    Sep 13, 2022

    Acute Myeloid Leukemia Trial in France (GRASPA)

    Completed
    Has Results
    • Acute Myeloid Leukemia
    • Nice, Alpes Maritimes, France
    • +20 more
    Feb 18, 2022

    Leukemia, Myelodysplastic Syndrome, Leukemia, Myeloid, Acute Trial in Nijmegen (anidulafungin 200 mg q48h, anidulafungin 300 mg

    Completed
    • Leukemia
    • +2 more
    • anidulafungin 200 mg q48h
    • anidulafungin 300 mg q72h
    • Nijmegen, Netherlands
      Radboud University Nijmegen Medical Centre
    Dec 4, 2020

    Acute Myeloid Leukemia Trial in Japan (PF-04449913, Low dose ARA-C (LDAC), Daunorubicin)

    Active, not recruiting
    Has Results
    • Acute Myeloid Leukemia
    • Nagoya, Aichi, Japan
    • +8 more
    Jan 12, 2022

    Acute Myeloid Leukemia, in Relapsed or Refractory, Acute Myeloid Leukemia, Elderly, Unfit, Acute Myeloid Leukemia With Positive

    Unknown status
    • Acute Myeloid Leukemia, in Relapsed or Refractory
    • +2 more
    • Beijing, Beijing, China
      Chinese PLA General Hospital
    Sep 8, 2020

    Medulloblastoma, CNS Embryonal Tumors Trial in Canada, New Zealand, United States (Induction, Single Cycle Intensive

    Recruiting
    • Medulloblastoma
    • Central Nervous System Embryonal Tumors
    • Birmingham, Alabama
    • +61 more
    Feb 16, 2022

    Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma Trial in New York (Bendamustine, Carmustine, Etoposide)

    Completed
    Has Results
    • Hodgkin's Lymphoma
    • Non-Hodgkin's Lymphoma
    • New York, New York
      Weill Cornell Medical College
    Feb 1, 2021

    Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A, Fibroblast Growth Factor Basic Form Measurement, FLT3 Internal

    Recruiting
    • Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A
    • +4 more
    • Chicago, Illinois
      Northwestern University
    Apr 30, 2021

    Nucleophosmin 1-mutated Acute Myeloid Leukemia Trial in Worldwide (Entospletinib, Placebo, Cytarabine)

    Recruiting
    • Nucleophosmin 1-mutated Acute Myeloid Leukemia
    • Duarte, California
    • +60 more
    Jul 20, 2022

    Various Management of Acute Myeloid Leukemia in Real Life

    Active, not recruiting
    • Acute Myeloid Leukemia
    • Bordeaux, France
    • +1 more
    Jul 29, 2020

    Primary Breast Cancer Trial in Beijing (Vinorelbine)

    Recruiting
    • Primary Breast Cancer
    • Beijing, Beijing, China
      Peking University Cancer Hospital
    Oct 26, 2020

    Leukemia, Myeloid Trial in Worldwide (CC-90011, Venetoclax, Azacitidine)

    Completed
    • Leukemia, Myeloid
    • Duarte, California
    • +34 more
    Apr 26, 2022

    Lung Cancer Trial in France (biological, drug, procedure)

    Completed
    • Lung Cancer
    • filgrastim
    • +4 more
    • Besancon, France
    • +21 more
    Feb 19, 2021

    Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic

    Completed
    • Adult Acute Megakaryoblastic Leukemia (M7)
    • +16 more
    • standard follow-up care
    • +2 more
    • Seattle, Washington
      Fred Hutchinson Cancer Research Center/University of Washington
    Jul 29, 2020